DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Lanas A, Goldstein JL, Chan FK. et al.
Risk factors associated with a decrease ≥ 2 g/dL in haemoglobin and/or ≥ 10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR).
Aliment Pharmacol Ther 2012;
36: 485-492
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.